A scientific society for integrating all aspects of cancer care - diagnostics, pathology, surgery, radiation, and medical oncology -through a multidisciplinary approach, because the future of medical oncology will focus on understanding cancer biology and intercepting the disease before it appears or recurs.
In this TJ Talks, prof. Giuseppe Curigliano, chair of the Division of Early Drug Development at the European Institute of Oncology in Milan, and professor at the University of Milan School of Medicine, talks with prof. Giancarlo Pruneri on the future of precision oncology and his commitment as President-elect of ESMO.

See omnystudio.com/listener for privacy information.